CHEK2 and neoplasm: Our study indicates that Chk2 dysfunction is prevalent in cis-Pt-resistant cells, and the resultant loss in Ser20 phosphorylation is an important negative regulator of p53 function, both in wild-type and mutant p53 tumor cells.